Victor E. Nava
- Cell Biology top 0.5%
- Molecular Biology top 2%
- Sphingolipid Metabolism and Signaling 12
- Lipid Membrane Structure and Behavior 5
- Immunology top 5%
- Physiology top 5%
- Physiology top 5%
-
- Prostate Cancer Treatment and Research 9
-
- Lymphoma Diagnosis and Treatment 9
-
- Chronic Lymphocytic Leukemia Research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- Acute Myeloid Leukemia Research 7
-
- Viral-associated cancers and disorders 5
- Co-authors
- Sarah SpiegelLisa C. EdsallSheldon MilstienTakafumi KohamaSamantha PoultonOlivier CuvillierJ. Marie HardwickRollie J. Clem
- Journals
- Journal of Clinical Oncology (5 papers)Cancers (2 papers)American Journal of Dermatopathology (2 papers)
- Partner nations
- United StatesPortugalPoland
In The Last Decade
Victor E. Nava
54 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cell Biology 1.4k
- Molecular Biology 3.6k
- Immunology 538
- Physiology 85
- Physiology 383
Countries citing papers authored by Victor E. Nava
This map shows the geographic impact of Victor E. Nava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor E. Nava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor E. Nava more than expected).
Fields of papers citing papers by Victor E. Nava
This network shows the impact of papers produced by Victor E. Nava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor E. Nava. The network helps show where Victor E. Nava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Victor E. Nava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 2 | |
| 11 | 2020 | 1 | |
| 12 | 2012 | 16 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 4 | |
| 15 | 2005 | 3 | |
| 16 | 2003 | 309 | |
| 17 | 2001 | 119 | |
| 18 | Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. | 2000 | 138 |
| 19 | 2000 | 91 | |
| 20 | Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors. | 1999 | 80 |
About Victor E. Nava
Victor E. Nava is a scholar working on Genetics, Hematology, Oncology, Pathology and Forensic Medicine and Cell Biology, having authored 64 papers that have together received 4.1k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (12 papers), Prostate Cancer Treatment and Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (7 papers), Viral-associated cancers and disorders (5 papers), Lipid Membrane Structure and Behavior (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Cell Biology (1.4k citations), Molecular Biology (3.6k citations), Immunology (538 citations), Physiology (85 citations) and Physiology (383 citations). Victor E. Nava has collaborated with scholars based in United States, Portugal and Poland. Frequent co-authors include Sarah Spiegel, Lisa C. Edsall, Sheldon Milstien, Takafumi Kohama, Samantha Poulton, Olivier Cuvillier, J. Marie Hardwick, Rollie J. Clem, Hans Rosenfeldt and John P. Hobson. Their work appears in journals such as Journal of Clinical Oncology, Cancers, American Journal of Dermatopathology, Journal of Biological Chemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.